Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability - Wikidata - awgldk - TriplyDB

Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability

Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability

http://www.wikidata.org/entity/Q28378468

about

NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress More answers to the still unresolved question of nitrate tolerance Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans.Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs.Mitochondrial oxidative stress and nitrate tolerance--comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice.Pulmonary endothelial cell NOX Daily low-dose folic acid supplementation does not prevent nitroglycerin-induced nitric oxide synthase dysfunction and tolerance: a human in vivo study.Amino acids, arginase and nitric oxide in vascular health.Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.Rosuvastatin treatment protects against nitrate-induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway.Nitrate tolerance and the links with endothelial dysfunction and oxidative stress.Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse.Recent developments in nitric oxide donor drugs.Arginase II inhibition prevents nitrate tolerance.Role of cGMP-dependent protein kinase in development of tolerance to nitroglycerine in porcine coronary arteries.Targeting nitric oxide with drug therapy.Redox control of renal function and hypertension.The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models.New biomaterials for the sustained release of nitric oxide: past, present and future.Adventitial fibroblasts in vascular structure and function: the role of oxidative stress and beyond.Application of nitric oxide in drug discovery and development.Enhancing vascular relaxing effects of nitric oxide-donor ruthenium complexes.Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases.Prunella vulgaris L. Upregulates eNOS expression in human endothelial cells.Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance.Ruthenium Complex Improves the Endothelial Function in Aortic Rings From Hypertensive Rats.Chronic nitroglycerine administration reduces endothelial nitric oxide production in rabbit mesenteric resistance artery Characteristics of attenuated endothelium-dependent relaxation seen in rabbit intrapulmonary vein following chronic nitroglycerine administration Lack of critical involvement of endothelial nitric oxide synthase in vascular nitrate tolerance in mice.Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate.Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide.Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention of NO donor-induced endothelial cell abnormalities.Role of the general base Glu-268 in nitroglycerin bioactivation and superoxide formation by aldehyde dehydrogenase-2.Lipoic acid effects on established atherosclerosis Reduced hyperpolarization in endothelial cells of rabbit aortic valve following chronic nitroglycerine administration.

P2860

Q24675368-8D2AB982-2F68-4F7D-AA92-50B7DEA6F86E Q26799354-D771704E-C6F2-4F10-AE13-C5EB9B33F3BD Q27012713-F9FA8839-5F55-41AE-880F-94357A2202AD Q28215041-205BEAE0-5F1A-4D26-A7F0-CBBE3B7464CA Q30438756-8407EFE3-3D59-42AC-8F7F-3F0CEE57BB9A Q31950468-8E08495F-C498-43BD-A48B-1026001881C0 Q33263050-B43D3B0D-5D01-4CC3-8A93-798F29BD1625 Q33769358-B5D72ADA-5E56-4011-BA44-123CE7A0EBF8 Q34338622-26B0C167-0A58-4A69-9DDD-415DF0AC12E3 Q34489450-020AE53F-F8B7-4F76-A632-ACFB6D2D1A37 Q35216447-9D4092E7-E401-4F97-8DA5-5E782C784C0E Q35546036-FB44E56E-49B9-4F97-850D-58865F4D6725 Q35583191-F1329695-BB11-48FE-BAF8-E312175ABFDA Q35994519-0A47C9B7-D763-4D0D-BEB7-94A2C809E130 Q36052815-84A37B31-02E9-40B2-AEE7-1C0610B238B0 Q36110484-7DC08966-D7C3-4670-9FA2-993258AC4DFB Q36456848-A3A18C9C-1DF6-496B-8A5D-44F2CAF961C9 Q36684790-8449C441-A4D4-4763-AA5D-220F2BDFBD54 Q36970633-0532D6CE-CADE-4F59-AF40-8A2BD76CB52D Q37198569-75E3BFBB-8930-4385-AFAF-1409EA45324A Q37361794-30255F94-C922-4C35-AEF7-8A26408BA79A Q37379932-CC1CC265-FACC-47C9-8EDB-B9787587ECED Q37460376-3F48A888-2CC5-40E9-8A36-883AABA6D381 Q37575595-D36C711A-47C3-4081-B867-D14225ECA9FE Q37731327-585E6ED0-C96B-4D20-8934-918187FB9348 Q38014563-FEACF780-C717-4D6E-BECF-2DE73D976E10 Q38221279-19704817-AB63-4483-A75D-08A478B7FCF5 Q39599675-901BA4A2-1BBA-4D5F-803A-CB609295C45A Q39700185-A688283B-A679-4530-85A1-021EA73C4AF4 Q40483773-80D54A17-1CD1-44C8-8133-AFB5FA3C77FC Q41556563-C674C813-7AC1-4C45-8587-4CC4378DF4B9 Q41785754-66C84AEA-82A6-434F-9F48-58D88F249C0D Q42116829-6D4F5C2E-FE13-4D9C-812C-8019C1AB4855 Q42124934-64A438DF-56F3-4640-8249-E6D10AABCFA8 Q42209398-0C7CFDB5-06E9-44C7-8E67-06CBAF04EAF9 Q42510127-613699EE-ED26-449C-BCAE-36C4C060D98C Q42511500-52593601-9CF0-454F-AD3B-E3DE68C3140F Q42550000-28660334-667D-42AE-9D07-43CDB027D52C Q42716061-4327E527-7BBC-4C0A-AD28-4C7DF78E6F13 Q43054888-55D5D668-2A9A-4206-8D2B-436BE5A256D4

P2860

Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability

http://www.wikidata.org/entity/Q28378468

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@ast

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@en

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@nl

type

label

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@ast

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@en

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@nl

prefLabel

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@ast

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@en

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@nl

P1433

Q28378468-20A67AEF-A186-48AC-A6DE-8BED9A0A9F15

P1476

Q28378468-A9EE89D6-717F-472E-99D9-2E50AD3073C4

P2093

Q28378468-04876C0F-B524-4EA8-8CF0-69A0E4DE8F68

Q28378468-32C3383E-F47F-4890-B181-853D8D5F2EE2

Q28378468-33C75686-13AB-433B-A72E-D3899F7B64C7

Q28378468-4AEB098F-8FF2-466C-A9DE-CECE40EF297D

Q28378468-65077FB9-D4F3-46A8-BB12-ADEA4A05EC63

Q28378468-6B776B0B-47ED-4EAF-8409-44882225D892

Q28378468-78A5A289-45B0-4DC6-A9F0-E456F47E7693

Q28378468-98E7E619-3DBF-4D16-8AC9-0F05DD576209

Q28378468-B702EB97-9897-452D-A555-625E3123E7D7

Q28378468-CCAA687D-1CCC-4ED5-9C2B-6C8B6B30A4E0

P304

Q28378468-76D96181-7599-4A1D-9979-CB6F380AE1F8

P31

Q28378468-185AF1E9-F717-4171-91DE-68407E9581C1

P356

Q28378468-9BA33879-CC1C-4432-A373-2D14D3A0CD81

P407

Q28378468-DEFD1F59-048E-43E9-9120-80B6A9A83B6D

P433

Q28378468-D68597B3-F825-490C-9378-086BE4C4C2F7

P478

Q28378468-2C071499-2A3B-42FA-B2DE-756F279F3A09

P577

Q28378468-9AD0088E-664B-45AE-B9AC-C6B993675C88

P698

Q28378468-0BA0A506-6384-45AE-BC12-7EAEF1B3DC8E

P921

Q28378468-BF1BA3C4-39EB-4F61-9EF3-2A2B7C472CD4

P356

P1433

Circulation Research

P1476

Effects of long-term nitroglyc ...... nd vascular NO bioavailability

@en

P2093

A Warnholtz

http://www.w3.org/2001/XMLSchema#string

E Matheis

http://www.w3.org/2001/XMLSchema#string

H Li

http://www.w3.org/2001/XMLSchema#string

H Mollnau

http://www.w3.org/2001/XMLSchema#string

L Duncker

http://www.w3.org/2001/XMLSchema#string

M Hartmann

http://www.w3.org/2001/XMLSchema#string

M Oelze

http://www.w3.org/2001/XMLSchema#string

M Skatchkov

http://www.w3.org/2001/XMLSchema#string

T Meinertz

http://www.w3.org/2001/XMLSchema#string

T Münzel

http://www.w3.org/2001/XMLSchema#string

P304

E7-E12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.86.1.E7

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10625313

http://www.w3.org/2001/XMLSchema#string

P921